INTRODUCTION
Although peripheral arterial disease (PAD) remains an increasing burden for national healthcare systems with >200 million people affected worldwide, 1 many questions regarding treatment of this disease cannot be answered using evidence from trials. Thus, in the absence of such evidence, many recommendations in international practice guidelines are built on expert consensus. 2e4 As there are only a few randomised controlled trials (RCTs) with well known problems of selection bias and limited external validity, with reasonable efforts registries and registry based cohort studies can help to fill the gaps. Registries allow evaluation of treatment practice patterns, medical device evaluation, and can assess convergence of real world and RCT evidence. 5 Although multiple national vascular registries exist, lack of consensus around variables (and their definitions) makes aggregation and comparison of findings difficult.
International collaborations such as the International Consortium of Vascular Registries (ICVR; www.icvr-initiative. org) can help harmonise cross border research. The ICVR is comprised of countries with vascular surgery registries, including the Vascular Quality Initiative (VQI; www.vqi.org) in the USA and the Vascunet Collaboration, consisting of vascular registries from 12 countries in Europe and Australasia (www.vascunet.org). The ICVR was launched in 2014 with the goal of establishing a collaborative platform across registries to share data in order to improve the quality of vascular health care. 6 Contributions regarding abdominal aortic aneurysms (AAA) and carotid artery stenosis were recently published by this collaboration. 6e9 For this project, ICVR members aimed to apply a modified Delphi approach to achieve agreement on a minimum core data set and to create an optimum data set for registries capturing surgical and interventional PAD treatments.
METHODS
The Delphi approach is widely accepted and used to gain consensus among a panel of experts, 10 and has previously been used in various specialties, including vascular surgery. 11e15 Representatives of 14 national vascular registries participating in the ICVR from Australia (Australasian Vascular Audit), Denmark (Karbase), Finland (HUSvasc), Germany (GermanVasc and Aortic Registry of the German Vascular Society), Hungary (Hungarian Vascular Registry), Iceland (Isvasc), Italy (Italian Vascular and Endovascular Registry), New Zealand (Australasian Vascular Audit), Norway (NORKAR), Spain, Sweden (Swedvasc), Switzerland (Swissvasc), and the USA (VQI) submitted their registries' current data sheets and definitions of data elements. An extensive narrative review of the literature was conducted to identify additional items in registry based studies on PAD. All participants in this study agreed to the scope of items identified through the abovementioned process. Members of the ICVR were then invited to participate in web based anonymised electronic questionnaires. Open source software (www.limesurvey.org) was used to generate the questionnaires. The participants could only submit one set of answers in each Delphi round. Following each round, a structured report, including anonymised group responses, mean results with SDs, as well as comments, were forwarded to the participants by email before they were invited to the next round. Each participant was asked to indicate whether they agreed that individual variables should be included in the consensus data set, and each item was scored on a five point Likert scale comprising "strongly agree", "agree", "neutral", "disagree", and "strongly disagree". Additionally, a free text comment could be submitted for each item. Items repeatedly rated with "strongly agree" or "agree" were recommended for the minimum data set. Items repeatedly rated with "strongly disagree" or "disagree" were eliminated from consideration. If consensus was not achieved after three rounds, the remaining items were discussed by the experts in two face to face ICVR meetings and added to the minimum data set if 80% of the experts supported the variable.
During this evaluation, it became apparent that it was important to determine not only which variables to include, but also what level of detail was needed for each variable included. By analysing each current national registry, it was determined that considerable variation existed in the level of detail collected, and in some cases the definition of the variables. In order to allow different levels of detail to be collected by different registries, but still allow harmonisation, three "levels" of variable recording detail but with common core definitions were created. Thus, reporting levels were stratified for data elements as level 1, 2, and 3, ranging from minimum to optimum. Reporting level 1 for variables were considered the minimum information necessary and typically have a simple input (yes, no) or simple numeric range. Level 2 and 3 variables have additional increasing specificity and granularity. For example, reporting the comorbidity of diabetes includes yes/no in reporting level 1. The more specific reporting level 2 includes the type of medical treatment (insulin, oral antidiabetic, etc.), whereas reporting level 3 includes HbA1c level Table 1 . Seventy-nine items in the minimal core and optimal data set for registries evaluating peripheral arterial revascularisation. (see Table 1 ). Some data elements, such as urgency of treatment and type of procedure were judged sufficiently important to always be required (level 1). Statistical analyses were performed with SPSS Statistics software version 23.0 (IBM, Armonk, NY, USA).
RESULTS
Thirty-one experts were contacted and 25 accepted and completed the first online survey. In total, 187 items were submitted by them and were included in the panel discussion ( Table 2 ). The items were reviewed by the expert panel and subsequently sorted into 11 main topics: (i) patient characteristics; (ii) comorbidities; (iii) current medications; (iv) lesion treated; (v) procedure; (vi) bypass; (vii) endarterectomy; (viii) catheter based intervention; (ix) complications; (x) follow up. The panel comprised vascular surgeons representing their national registry in ICVR, from three continents, 14 countries, and 18 institutions. The final number of data elements was not specified a priori. All panel experts (100%) completed rounds 1e4 and 18 (90%) completed round 5. The Delphi process ( Fig. 1 ) resulted in the ICVR suggested data set for PAD revascularisation registries with different levels of potential detail for each variable (Table 1 ). After two Delphi rounds, 68 items were designated twice as "agree" or "strongly agree", whereas 60 items were designated twice as "disagree" or "strongly disagree". After five Delphi rounds, a total of 79 items were included in the recommended data set, of which 65 were included in the level 1 version, with an additional 14 included with more data specificity at the level 2 and 3 versions ( Table 1) . For example interventional device data can be recorded as level 1, which reports devices by class (plain angioplasty, drug coated balloon angioplasty, atherectomy, stent, etc.); level 2, which includes adjuncts such as embolic protection; and level 3, which records the Global Unique Device Identification Database.
It was recommended that all registries create an option to indicate that the state of the variable is "unknown", in order to differentiate omitted from unknown data, and not force users to choose an option when it is unclear. For simplicity, the "unknown" options for each variable have not been included in Table 1 .
DISCUSSION
In this modified Delphi study with international experts, consensus was achieved on items to be collected in registries on peripheral arterial revascularisation. Sixty-five items were recommended for a minimum core (level 1) data set with an additional 14 variables with increased specification recommended for the optimum dataset (level 2e3). According to the existing literature and methodological recommendations, the minimum and optimum number for Delphi studies is two rounds. Regarding the panel size, at least 6e11 members are usually recommended to work efficiently. In this Delphi study more experts were included (n ¼ 25) and there were more rounds (n ¼ 5), emphasizing the rigor of the approach to address the complexity of the This innovative approach made the processes rigorous and efficient, considering the fact that international experts from different time zones participated in this Delphi study. Importantly, the Delphi process resulted in a reduction from 187 items originally included in PAD registries across the ICVR to 79 items in the optimum data set. This is still a large number of variables after the consensus process and may pose a hurdle owing to the burden of data collection. However, considering the complexity of the PAD, and the abundance of medical and surgical treatment alternatives, a more comprehensive data collection is necessary to allow meaningful data analysis. Ultimately, the trade-off between complexity and practicality was challenging and proved to be even more difficult when designing a registry database for PAD than for AAA or carotid artery disease.
The key to collaboration and data sharing among registries is harmonisation of data elements, definitions, and method for similarly recording each variable. While each registry would prefer to register the most detailed data possible, real world practice and current lack of ability to easily extract uniform data from all electronic medical record (EMR) systems makes this impractical. For this reason, it is valuable to recommend not only a minimum core data set (and uniform definitions) that can be used by all registries, but also to recommend more detailed categories (levels) for data recording as registries mature and EMR extraction becomes more feasible. It is important that these higher levels of data collection harmonise with core levels so that all data can be merged at some level. The authors believe that the current proposal of core to optimum data collection "levels" is a novel contribution that could be valuable for other specialties.
It is recognised that the number and selection of data elements is contingent on the intended uses of the registry. A PAD revascularisation registry designed for quality improvement would probably have different elements or fewer granular data than one established for clinical research or device evaluation. In this work there was an attempt to balance the competing interests of inclusiveness with the practicality of data entry. The concept of different levels of modern web based registries with contingent variables already enables efficient data entry, but there is much work to be done. In the future, it is expected that Quality of life Walking distance Rehospitalisation Re-intervention Infection Ankle brachial index (ABI) Destination at discharge/discharge destination registries will integrate with EMR systems and claims data to allow more automated data capture to minimise the work of data entry. Clearly, such future developments facing big-data applications will need to meticulously deal with data privacy and safety concerns. 16 Harmonisation of registries will allow for more meaningful comparisons of practice patterns, medical device performance, and outcomes across countries. Such collaboration will improve our ability to generate real world evidence and design registry based studies of peripheral vascular interventions. In the future, registry based studies may supplement the evidence gained from RCTs and prospective cohort studies. Similar work has been reported by the Registry Assessment of Peripheral Arterial Devices (RAPID) group for multispecialty collaboration within USA. 17, 18 The ICVR-recommended data set has many agreements with data elements and definitions in RAPID, which is focused on device evaluation for peripheral vascular intervention in USA. The current ICVR database recommendations extend those of RAPID to encompass both open and endovascular revascularisation and for international studies, while still allowing device evaluation. These efforts provide an important opportunity for global harmonisation of clinical data to improve vascular health care. Existing ICVR registry members are committed to adopting these data elements as the next stage of evolution for ICVR.
CONCLUSIONS
This large scale modified Delphi study among international vascular registry specialists achieved a consensus agreement on a minimum core and optimum data set for registries evaluating peripheral arterial revascularisation. It reduced the overall number of initially suggested variables by nearly half. Global harmonisation of registry infrastructure and definition of items will overcome limitations related to single country investigations and has the potential to speed up and enhance acquisition of real world evidence. National registries in the ICVR plan to incorporate these core data elements into their PAD registries to increase the opportunity for future collaboration.
